Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Short-term changes after a weight reduction intervention in advanced diabetic nephropathy.

Friedman AN, Chambers M, Kamendulis LM, Temmerman J.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1892-8. doi: 10.2215/CJN.04010413. Epub 2013 Aug 8.

2.

Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study.

August P, Hardison RM, Hage FG, Marroquin OC, McGill JB, Rosenberg Y, Steffes M, Wall BM, Molitch M; BARI 2D Study Group.

Clin J Am Soc Nephrol. 2014 Jan;9(1):64-71. doi: 10.2215/CJN.12281211. Epub 2013 Oct 31.

3.

Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.

Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G.

J Intern Med. 2004 Dec;256(6):510-8.

4.

Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study.

Leehey DJ, Moinuddin I, Bast JP, Qureshi S, Jelinek CS, Cooper C, Edwards LC, Smith BM, Collins EG.

Cardiovasc Diabetol. 2009 Dec 9;8:62. doi: 10.1186/1475-2840-8-62.

5.

Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.

Pavkov ME, Knowler WC, Hanson RL, Williams DE, Lemley KV, Myers BD, Nelson RG.

Am J Kidney Dis. 2013 Jul;62(1):33-41. doi: 10.1053/j.ajkd.2012.11.044. Epub 2013 Jan 21.

6.

25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.

Fernández-Juárez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Lahera V, Casas L, Oliva J; PRONEDI Study Group.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1870-6. doi: 10.2215/CJN.00910113. Epub 2013 Oct 17.

7.

Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.

Tanaka N, Babazono T, Takagi M, Yoshida N, Toya K, Nyumura I, Hanai K, Uchigata Y.

Nephrology (Carlton). 2015 Aug;20(8):531-8. doi: 10.1111/nep.12446.

PMID:
25773273
8.

Pulse pressure does not predict the response of diabetic nephropathy to glucose-lowering therapy.

Nakhjavani M, Nargesi AA, Heidari B, Ghazizadeh Z, Larry M, Esteghamati A.

Diab Vasc Dis Res. 2015 Mar;12(2):150-1. doi: 10.1177/1479164114559208. Epub 2014 Dec 18.

PMID:
25525076
9.

Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.

Huang M, Liang Q, Li P, Xia J, Wang Y, Hu P, Jiang Z, He Y, Pang L, Han L, Wang Y, Luo G.

Mol Biosyst. 2013 Aug;9(8):2134-41. doi: 10.1039/c3mb25543c. Epub 2013 May 30.

PMID:
23719966
10.

Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.

Kanaoka T, Tamura K, Moriya T, Tanaka K, Konno Y, Kondoh S, Toyoda M, Umezono T, Fujikawa T, Ohsawa M, Dejima T, Maeda A, Wakui H, Haku S, Yanagi M, Mitsuhashi H, Ozawa M, Okano Y, Ogawa N, Yamakawa T, Mizushima S, Suzuki D, Umemura S.

Clin Exp Hypertens. 2011;33(4):255-63. doi: 10.3109/10641963.2011.583971.

PMID:
21699452
11.

Albuminuria and its correlates in type 2 diabetic patients.

Zakkerkish M, Shahbazian HB, Shahbazian H, Latifi SM, Moravej Aleali A.

Iran J Kidney Dis. 2013 Jul;7(4):268-76.

12.

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment.

Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W.

Vasc Health Risk Manag. 2013;9:21-8. doi: 10.2147/VHRM.S39300. Epub 2013 Jan 23.

13.

Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus.

Bonakdaran S, Hami M, Shakeri MT.

Iran J Kidney Dis. 2011 Jan;5(1):21-4.

14.
15.

Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.

Joergensen C, Tarnow L, Goetze JP, Rossing P.

Diabet Med. 2015 Mar;32(3):374-81. doi: 10.1111/dme.12606. Epub 2014 Nov 5.

PMID:
25307511
16.

Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.

Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A.

Nephrol Dial Transplant. 1996 Mar;11(3):449-56.

PMID:
8671814
17.

Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.

Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM.

Am J Kidney Dis. 2006 Jan;47(1):78-87.

PMID:
16377388
18.

Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes.

Hussain TA, Mathew TC, Dashti AA, Asfar S, Al-Zaid N, Dashti HM.

Nutrition. 2012 Oct;28(10):1016-21. doi: 10.1016/j.nut.2012.01.016. Epub 2012 Jun 5.

PMID:
22673594
19.

Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

J Nephrol. 2001 Nov-Dec;14(6):461-71.

PMID:
11783602
20.

Effect of aerobic training on diabetic nephropathy in a rat model of type 2 diabetes mellitus.

Chiasera JM, Ward-Cook KM, McCune SA, Wardlaw GM.

Ann Clin Lab Sci. 2000 Oct;30(4):346-53.

PMID:
11045758

Supplemental Content

Support Center